Archive: UCSF AIDS Walk Teams to Go for the Gold Again
UC San Francisco, a frequent high-performing team at AIDS Walk San Francisco, will again for the gold – the honor given to the top fundraising organizations participating in the annual event.
University of California San Francisco
Give to UCSFUC San Francisco, a frequent high-performing team at AIDS Walk San Francisco, will again for the gold – the honor given to the top fundraising organizations participating in the annual event.
Starting HIV-infected patients on antiretroviral therapy reduces food insecurity and improves physical health, thereby contributing to the disruption of a lethal syndemic, UCSF and Massachusetts General Hospital researchers have found in a study focused on sub-Saharan Africa.
<p>A proposed new treatment to help HIV/AIDS patients suffering from Kaposi’s sarcoma, the most common form of cancer in people with HIV, is now one step closer to becoming a reality thanks to a program that supports promising early-stage research.</p>
Adults with HIV in rural sub-Saharan Africa who receive antiretroviral drugs early in their infection may reap benefits in their ability to work and their children's ability to stay in school, according to a first-of-its-kind clinical study in Uganda that compared socioeconomic outcomes with CD4+ counts — a standard measure of health status for people with HIV.
<p>The AIDS drug Truvada, approved this week for prevention of HIV infection in uninfected people at high risk, may benefit many uninfected women whose male partners have HIV, including pregnant women, who may be at higher risk.</p>
<p>A perspective published in the <em>New England Journal of Medicine</em> this week by professors at UCSF and the Johns Hopkins University asserts that it is now possible to begin to end the AIDS epidemic by widely and strategically applying existing tools.</p>
Physical violence, sexual abuse and other forms of childhood and adult trauma are major factors fueling the epidemic of HIV/AIDS among American women, who account for at least 27 percent of new U.S. cases.
President Barack Obama appointed UCSF AIDS expert Grant Colfax, MD, as the director of the Office of National AIDS Policy.
A drug once taken by people with HIV/AIDS, but long ago shelved after newer, modern antiretroviral therapies became available, has now shed light on how the human body uses its natural immunity to fight the virus — work that could help uncover new targets for drugs.
<p>Paul Volberding, MD, one of the world's leading experts on treatment for patients infected with HIV, the AIDS virus, became the new director of the AIDS Research Institute (ARI) at UCSF on Feb. 13.</p>
<p>For doctors confronting the AIDS epidemic, past ambitions always boiled down to two main goals: prevention, or finding ways to protect people not yet exposed to HIV, through vaccines, safe sex education or other means; and treatment, or discovering effective drugs and providing them to people with HIV/AIDS, helping them live longer.</p>
<p>Doctors and other health care professionals packed into San Francisco General Hospital’s Carr Auditorium for the June 7 medical grand rounds, commemorating the 30th anniversary of the first AIDS report to the US Centers of Disease Control (CDC) and Prevention.</p>
<p>As one of the preeminent biomedical education and health sciences research institutions in the world, UCSF emerged early as a pioneer in the fight against AIDS. Today, three decades later, UCSF is working on multiple fronts to prevent, treat and stop the spread of the disease that has killed 33 million people worldwide.</p>
In April 2010, personnel aboard the International Space Station plan to carry out an experiment designed by a San Francisco VA Medical Center researcher that will investigate why the immune system’s T cells stop working in the absence of gravity. The experiment has implications for understanding the body’s ability to mount an immune response on earth, as well.
A new study co-authored by a UCSF resident physician and published this week examines why low-income countries are making poor progress in meeting international health goals. Study researcher Sanjay Basu, MD, PhD, of the Department of Medicine at UCSF and Division of General Internal Medicine at San Francisco General Hospital, said findings highlight the importance of looking at the entire health experience of a family, rather than just one or a few diseases.